transmedics.com (TMDX) Enterprise Value to EBITDA Ratio
TransMedics Group (TMDX) has monopolized the organ preservation systems market, ensuring a stable cash flow. Its proprietary aviation network guarantees optimal delivery speed for transplants. The EV/EBITDA multiple visualizes the company's market value relative to earnings, where 28.52 determines the latest valuation metric. Meanwhile, high-tech robotic assembly of the devices is complemented by the expertise of leading surgeons.
Comprehensive metric breakdowns and analytics for TransMedics Group, Inc. (TMDX)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio TransMedics Group|TMDX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity TransMedics Group Inc|TMDX - Company Total Debt|Debts to Book Capitalization TransMedics Organ Care System|TMDX - Long-Term Debt|Company Short-Term Debts TransMedics|Quick Ratio transmedics.com
- financial results and valuation multiples details:
TMDX - Net Financial Result|Projected Future Earnings TransMedics Group|TMDX - Price to Earnings Ratio|Forward P/E Multiple TransMedics Group|TMDX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TransMedics Organ Care System|TMDX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months TransMedics|TMDX - Earnings per share for the trailing year|Quarterly EPS earnings growth transmedics.com|TMDX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year TransMedics Group
Analysis of all company metrics:TransMedics Organ Care System TMDX
TransMedics Group (TMDX) is strengthening its position in transplantology by integrating aviation logistics and expanding organ coverage to mitigate operational risks. This EV/EBITDA chart compares the company's total enterprise value with its earnings before interest, taxes, depreciation, and amortization, allowing investors to assess the efficiency of capital-intensive assets and identify a fundamental bottom while avoiding value traps during periods of market volatility.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Enovis ENOV|IART - Enterprise Value to EBITDA Ratio|Motiva - EV/EBITDA Multiple|Company Value to EBITDA iLet Bionic Pancreas|IRMD: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation EMBC|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|AxoGen Inc (AXGN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD (ReWalk Robotics Ltd.) - Enterprise Value to EBITDA Ratio|AMIX: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|BBLG: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AXNX|EV/EBITDA Multiple Biolase Inc. (BIOL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|FNA: Enterprise Value to Operating Income Before Depreciation|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
